Copyright
        ©The Author(s) 2022.
    
    
        World J Gastrointest Oncol. Aug 15, 2022; 14(8): 1574-1584
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1574
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1574
            Table 1 General clinical characteristics of study subjects
        
    | CRC | CRP | HC | LC | |
| n | 92 | 67 | 63 | 66 | 
| Age (yr) | ||||
| mean | 57 | 55 | 55 | 53 | 
| Range | 42-66 | 41-62 | 35-68 | 34-65 | 
| Sex | ||||
| Male | 51 | 38 | 32 | 29 | 
| Female | 41 | 29 | 23 | 24 | 
| TNM stage | ||||
| T1 | 15 | 9 | ||
| T2 | 24 | 18 | ||
| T3 | 22 | 14 | ||
| T4 | 31 | 22 | ||
- Citation: Li J, Li H, Run ZC, Wang ZL, Jiang T, An Y, Li Z. RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(8): 1574-1584
 - URL: https://www.wjgnet.com/1948-5204/full/v14/i8/1574.htm
 - DOI: https://dx.doi.org/10.4251/wjgo.v14.i8.1574
 
